Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724461 | SCV000230438 | uncertain significance | not provided | 2014-12-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002310744 | SCV000319527 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-04-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000178369 | SCV000514671 | likely benign | not specified | 2017-02-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001087931 | SCV000644159 | likely benign | Arterial tortuosity syndrome | 2024-01-17 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV002310744 | SCV003838259 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-03-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724461 | SCV004154650 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | SLC2A10: BP4, BP7 |